Alembic releases generic DilacorDiltiazem HcL ER capsules are indicated for the treatment of hypertension. Generic drug suppliers weigh in on predictable, unpredictable category impactGeneric drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. Sanofi nears selling 50% controlling stake in Opella to CD&R Sanofi said the closing is expected to take place in Q2 2025 at the earliest. Fresenius Kabi intros calcitonin salmon injection Calcitonin salmon injection is used to treat Paget’s disease, hypercalcemia and postmenopausal osteoporosis. NationsBenefits expands retail network with Walgreens The collaboration allows members of NationsBenefits’ health plan partners to use their Benefits Mastercard Prepaid Card at Walgreens. CVS Caremark taps Ed DeVaney as president of PBM business DeVaney was named interim president of Caremark's PBM business in December 2024. Dr. Reddy’s, Henlius to co-market Darzalex & Darzalex Faspro biosimilar in the U.S., Europe Darzalex & Darzalex Faspro are indicated for the treatment of multiple myeloma. Surescripts releases touchless prior authorization technology Touchless Prior Authorization is intended to help automate existing manual workflows. AAM releases 2025 advocacy priorities, legislative reform recommendations The recommendations are a call to action to safeguard affordable generic and biosimilar medicines. Cencora expands drug shortages mitigation program Nearly 200 medications, including several oncology treatments, are now available through the program. 1 2 3 4 5 Next Last
